The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Alteration of miRNAs in Small Neuron-Derived Extracellular Vesicles of Alzheimer's Disease Patients and the Effect of Extracellular Vesicles on Microglial Immune Responses
Abstract
Alzheimer's disease (AD) is one of the most severe neurodegenerative diseases observed in the elderly population. Although the hallmarks of AD have been identified, the methods for its definitive diagnosis and treatment are still lacking. Extracellular vesicles (EVs) have become a promising source for biomarkers since the identification of their content. EVs are released from multiple cell types and, when released from neurons, they pass from the brain to the blood with their cargo molecules. Hence, neuron-specific EV-resident microRNAs (miRNAs) are promising biomarkers for diagnosis of AD. This study aimed to identify altered miRNA content in small neuron-derived extracellular vesicles (sNDEVs) isolated from AD patients and healthy individuals. Furthermore, we examined the role of sNDEV-resident miRNAs in neuron-glia cellular interaction to understand their role in AD propagation. We identified 10 differentially expressed miRNAs in the sNDEVs of patients via next-generation sequencing and validated the most dysregulated miRNA, let-7e, with qRT-PCR. Let-7e was significantly increased in the sNDEVs of AD patients compared with those of healthy controls in a larger cohort. First, we evaluated the diagnostic utility of let-7e via ROC curve analysis, which revealed an AUC value of 0.9214. We found that IL-6 gene expression was increased in human microglia after treatment with sNDEVs of AD patients with a high amount of let-7e. Our study suggests that sNDEV-resident let-7e is a po…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Durur et al. [69] found that let-7e-5p was upregulated in small neuron-derived EVs (sNDEV) of 23 AD patients’ plasma compared to 28 HC.”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [69]
In the citing paper
“Durur et al. used let-7e-5p in sNDEV derived from the plasma to distinguish AD patients from HC, and the AUC was 0.92 [69].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [69]
Citations
Cites
Exosomes: biogenesis, biologic function and clinical potential
Zhang, Y., Liu, Y., Liu, H., & Tang, W. H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0282-2 · Cited by 2,119
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092921 · Cited by 809
Interplay between miRNAs and human diseases
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25854 · Cited by 420
Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity
Xu, B., Zhang, Y., Du, X.-F., Li, J., Zi, H.-X., Bu, J.-W., Yan, Y., Han, H., & Du, J.-L. (2017) · Cell Research · doi:10.1038/cr.2017.62 · Cited by 354
Prada, I., Gabrielli, M., Turola, E., Iorio, A., D’Arrigo, G., Parolisi, R., De Luca, M., Pacifici, M., Bastoni, M., Lombardi, M., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1803-x · Cited by 312
Research works printed but not linked: 49
- Arioz BI et al (2021) Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker. Neurosci Lett 755 · DOI
- Ash EL (2007) 27 - Dementia. In: Marshall RS, Mayer SA (eds) On Call Neurology, 3rd edn. W.B. Saunders, pp 401–417 · DOI
- Bachiller S et al (2018) Microglia in neurological diseases: A road map to brain-disease dependent-inflammatory response. Front Cell Neurosci 12(488) · DOI
- Bahrini I et al (2015) Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci Rep 5:7989–7989 · DOI
- Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368(9533):387–403 · DOI · Paper page
- Caruso Bavisotto C et al (2019) Extracellular vesicle-mediated cell-cell communication in the nervous system: Focus on neurological diseases. Int J Mol Sci 20(2):434 · DOI
- Cha DJ et al (2019) miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer’s patients. Front Neurosci 13:1208–1208 · DOI · Paper page
- Chen JJ et al (2017) Potential roles of exosomal microRNAs as diagnostic biomarkers and therapeutic application in Alzheimer’s disease. Neural Plast 2017:7027380
- Chen W-X et al (2018) Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells. Biosci Rep 38(6):BSR20181090 · DOI
- Chen JJ et al (2019a) Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer’s disease. Rev Neurosci 31(1):77–87 · DOI
- Chen W-X et al (2019b) Bioinformatics analysis of dysregulated microRNAs in exosomes from docetaxel-resistant and parental human breast cancer cells. Cancer Manag Res 11:5425–5435 · DOI
- Cheng L et al (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3 · DOI · Paper page
- Cheng L et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20(10):1188–1196 · DOI · Paper page
- Dalvi A (2012) Alzheimer’s disease. Dis Mon 58(12):666–677 · DOI
- Derkow K et al (2018) Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer’s disease. PLoS One 13(7):e0200602 · DOI
- Dong Z et al (2021) Profiling of serum exosome MiRNA reveals the potential of a MiRNA panel as diagnostic biomarker for Alzheimer’s disease. Mol Neurobiol 58(7):3084–3094 · DOI · Paper page
- Ebrahimkhani S et al (2017) Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep 7(1):14293 · DOI
- Fabbri M et al (2012) MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 109(31):E2110–E2116 · DOI · Paper page
- Gámez-Valero A et al (2019) Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies. Transl Neurodegener 8(1):31 · DOI · Paper page
- Gracia T et al (2017) Urinary exosomes contain microRNAs capable of paracrine modulation of tubular transporters in kidney. Sci Rep 7(1):40601 · DOI
- Gupta A, Pulliam L (2014) Exosomes as mediators of neuroinflammation. J Neuroinflammation 11:68–68 · DOI
- Hane FT et al (2017) Recent progress in Alzheimer’s disease research, part 3: Diagnosis and treatment. J Alzheimers Dis 57(3):645–665 · DOI
- Heneka MT et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405 · DOI · Paper page
- Jella KK et al (2018) Exosomes, their biogenesis and role in inter-cellular communication, tumor microenvironment and cancer immunotherapy. Vaccines (Basel) 6(4) · DOI
- Kinoshita C et al (2014) Rhythmic oscillations of the microRNA miR-96-5p play a neuroprotective role by indirectly regulating glutathione levels. Nat Commun 5(1):3823 · DOI
- Leggio L et al (2017) microRNAs in Parkinson's disease: From pathogenesis to novel diagnostic and therapeutic approaches. Int J Mol Sci 18(12) · DOI
- Liao W et al (2019) Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater 86:1–14 · DOI
- Liu CG et al (2014) MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer’s disease. Mol Med Rep 10(5):2395–2400 · DOI · Paper page
- Liu CG et al (2021a) MicroRNA-135a in ABCA1-labeled exosome is a serum biomarker candidate for Alzheimer’s disease. Biomed Environ Sci 34(1):19–28
- Liu CG et al (2021b) ABCA1-labeled exosomes in serum contain higher microRNA-193b levels in Alzheimer’s disease. Biomed Res Int 2021:5450397
- Lugli G et al (2015) Plasma exosomal miRNAs in persons with and without Alzheimer disease: Altered expression and prospects for biomarkers. PLoS One 10(10):e0139233 · DOI · Paper page
- Manna I et al (2020) Exosomal miRNAs as potential diagnostic biomarkers in Alzheimer's disease. Pharmaceuticals (Basel) 13(9) · DOI
- Martin M (2011) CUTADAPT removes adapter sequences from high-throughput sequencing reads. EMBnet. J 17 · DOI · Paper page
- Masters CL et al (2015) Alzheimer’s disease. Nat Rev Dis Primers 1:15056 · DOI · Paper page
- McKeever PM et al (2018) MicroRNA expression levels are altered in the cerebrospinal fluid of patients with Young-Onset Alzheimer’s disease. Mol Neurobiol 55(12):8826–8841 · DOI · Paper page
- Mitchell PS et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513–10518 · DOI · Paper page
- Mustapic M et al (2017) Plasma extracellular vesicles enriched for neuronal origin: A potential window into brain pathologic processes. Front Neurosci 11:278 · DOI · Paper page
- Pathan M et al (2017) A novel community driven software for functional enrichment analysis of extracellular vesicles data. J Extracell Vesicles 6(1):1321455 · DOI
- Rabbito A et al (2020) Biochemical markers in Alzheimer's disease. Int J Mol Sci 21(6) · DOI
- Rani A et al (2017) miRNA in circulating microvesicles as biomarkers for age-related cognitive decline. Front Aging Neurosci 9(323) · DOI
- Sancesario GM, Bernardini S (2018) Diagnosis of neurodegenerative dementia: where do we stand, now? Ann Transl Med 6(17):340 · DOI
- Serpente M et al (2020) MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer’s disease. Cells 9(6):1443 · DOI · Paper page
- Théry C et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750 · DOI · Paper page
- Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659 · DOI · Paper page
- Van Giau V, An SS (2016) Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer’s disease. J Neurol Sci 360:141–152 · DOI
- Worst TS et al (2019) miR-10a-5p and miR-29b-3p as extracellular vesicle-associated prostate cancer detection markers. Cancers 12(1):43 · DOI
- Xiao T et al (2017) The role of exosomes in the pathogenesis of Alzheimer’ disease. Transl Neurodegener 6:3 · DOI
- Yang TT et al (2018) The serum exosome derived microRNA-135a, -193b, and -384 were potential Alzheimer’s disease biomarkers. Biomed Environ Sci 31(2):87–96
- Yue B et al (2020) Characterization and transcriptome analysis of exosomal and nonexosomal RNAs in bovine adipocytes. Int J Mol Sci 21(23) · DOI
Cited by
Sorted by citations
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
Li, W., & Zheng, Y. (2023) · Cells · doi:10.3390/cells12101378 · Cited by 43
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Metadata
- Authors
- Durur, D. Y., Tastan, B., Ugur Tufekci, K., Olcum, M., Uzuner, H., Karakülah, G., Yener, G., & Genc, S.
- ORCID
- Genc, Sermin
- Venue
- Journal of Molecular Neuroscience
- Published
- 2022-04-29
- Volume
- 72
- Issue
- 6
- Pages
- 1182-1194
- ISSN
- 0895-8696
- 1559-1166
- Cited by
- 46
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alteration of miRNAs in Small Neuron-Derived Extracellular Vesicles of Alzheimer's Disease Patients and the Effect of Extracellular Vesicles on Microglial Immune Responses. https://app.cochat.ai/papers/10.1007/s12031-022-02012-y
- The paper
- Durur, D. Y., Tastan, B., Ugur Tufekci, K., Olcum, M., Uzuner, H., Karakülah, G., Yener, G., & Genc, S. (2022). Alteration of miRNAs in Small Neuron-Derived Extracellular Vesicles of Alzheimer's Disease Patients and the Effect of Extracellular Vesicles on Microglial Immune Responses. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-022-02012-y